期刊文献+

TCT检查正常妇女HPV的消退规律及其与CIN的关系 被引量:3

The regularity of HPV clearance in the women with normal TCT results and its relationship with CIN
原文传递
导出
摘要 目的:探讨HR-HPV及LR-HPV的消退规律,为细胞学检查正常的HPV阳性人群制定合理的个体化诊疗方案。方法:对2007年1月~2008年12月在吉林大学第二医院妇科门诊妇科体检宫颈细胞学检查正常、HPV检测阳性的妇女进行定期随访,对6、12、18、24个月做TCT、HPV检测的316例患者资料进行回顾性分析。结果:随访至第6、12、18、24个月HR-HPV消除率分别为47.51%、58.37%、64.71%、73.30%,LR-HPV消除率分别为86.32%、92.63%、94.74%、97.89%。结论:HR-HPV感染后2年基本消退,LR-HPV感染后半年基本消退。HR-HPV持续阳性妇女易发生CINⅡ-Ⅲ,故宜严密随访。 Objective:To explore the regularities of high risk(HR)-human papillomavirus(HPV) clearance and low risk(LR)-HPV clearance,design a reasonable and individualized diagnostic and therapeutic scheme for HPV positive women with normal cytological results. Methods:The HPV positive women with normal cervical cytological results who received physical examination in gynecological outpatient of the hospital from January 2007 to December 2008 were followed up regularly,the data of 316 patients receiving thin layer liquid-based cytological test(TCT) and HPV detection at 6,12,18 and 24 months were analyzed retrospectively. Results:The clearance rates of HR-HPV at 6,12,18 and 24 months were 47.51%,58.37%,64.71% and 73.30%,respectively;the clearance rates of LR-HPV at 6,12,18 and 24 months were 86.32%,92.63%,94.74% and 97.89%,respectively. Conclusion:HR-HPV degrades basically at 2 years after infection,LR-HPV degrades basically at half a year after infection.The women with persisting positive HR-HPV are prone to CINⅡ~Ⅲ,so close follow-up is suggested.
出处 《中国妇幼保健》 CAS 北大核心 2011年第35期5493-5495,共3页 Maternal and Child Health Care of China
关键词 人乳头瘤病毒 宫颈上皮内瘤样变 薄层液基细胞学检测 Human papillomavirus Cervical intraepithelial neoplasm Thin layer liquid-based cytological test
  • 引文网络
  • 相关文献

参考文献13

  • 1Ferenczy A, Franco E. Persistent human papillomavirus infection and cervical neoplasia [J) . Lancet Oncol, 2002, 3 (1): 11.
  • 2高娜,姚嘉斐.宫颈癌筛查中HPV检测、传统涂片及液基制片法的比较研究[J].现代妇产科进展,2007,16(11):857-859. 被引量:51
  • 3Rosa MI, Fachel JMG, Rosa DD et al. Persistence and clearance of human papillomavirus infection: a prospective cohort study [ J ] . Am J Obstet Gynecol, 2008, 199 (6) : 617.
  • 4Hwang TS, Jeong JK , Park Met al. Detection and typing of HPV genotypes in various cervical lesions by HPV oligonueleotide mieroarry[J]. Gynecol Oneol, 2003, 90:51.
  • 5Aerssens A, Claeys P, Garcia A et al. Natural history and clearance of HPV after treatment of precancerous cervical lesions [ J] . Histopathology, 2008, 52 (3): 381.
  • 6Kjellberg L, Wadell G, Bergman F et al. Regular disappearance of the human papillomavirus genome after conization of cervical epithelial dysplasia by carbon dioxide laser [J] . Am J Obstet Gynecol, 2000, 183 (5) : 1238.
  • 7Elfgren K, Jacobs M, Walboomers JM et al. Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia [ J]. Obstet Gynecol, 2002, 100 (5): 965.
  • 8Selbrs JW, Mahony LB, Kaczorowski J et al. Prevalence and predictors of human papilomavirus infection in women in Ontarin, Canada Survey of HPV in Ontario Women (SHOW) Group [J] .CMAJ, 2000, 163 (5) : 503.
  • 9Josefsson AM, Magnusson PK, Ylitalo Net al. Viral load of human papillomavirus 16 as determinant for development of cervical carcinoma in situ: a nested case control study [ J] . Lancet, 2000, 355 (9222) : 2189.
  • 10赵方辉,李楠,马俊飞,张洵,吴令英,戎寿德,Lorincz A,Belinson J,乔友林.山西省襄垣县妇女人乳头状瘤病毒感染与宫颈癌关系的研究[J].中华流行病学杂志,2001,22(5):375-378. 被引量:209

二级参考文献32

  • 1乌兰娜,吴瑞芳,周艳秋,刘志红,张礼婕,黄秀浓,杜辉.人乳头瘤病毒基因亚型与宫颈病变的关系[J].中国妇产科临床杂志,2005,6(5):346-350. 被引量:102
  • 2李洁,刘宝印,zur Hausen H,王宏,杨学志,李力,刘文,刘洪隐,陆克昭,刘旭,牛春燕,裴润芳,苏钟浦,王言贵,董继华,张桂宁,刘春杰,许吉林,林毓纯.中国妇女宫颈癌组织中人乳头瘤病毒感染及其地理分布的调查[J].中华实验和临床病毒学杂志,1996,10(1):50-55. 被引量:67
  • 3谭毅,李淑玲,谢平,林婷.高危型人乳头瘤病毒联合细胞学检测原发和复发重度宫颈上皮内瘤变[J].实用医学杂志,2006,22(6):672-673. 被引量:13
  • 4Belinson J,Int J Gynecol Cancer,1999年,9卷,411页
  • 5李洁,中华实验和临床簿学杂志,1996年,10卷,50页
  • 6Peng H,Int J Cancer,1991年,47卷,711页
  • 7Mclachlin C M.Human papillomavirus in cervical neoplasia:role,risk factors and Implications[J].Clin Lab Med,2000,20 (2):257.
  • 8IARC working group on the evaluation of carcinogenic risks to humans.IARC monographs on the evaluation of carcinogenic risks to humans.Human papillomavirus[M].Lyon,France:WHO,1995:64.
  • 9Schiffman M,Khan M J,Solomon D,et al.A study of the impact of adding HPV types to cervical cancer screening and triage tests[J].J Natl Cancer Inst,2005,97(2):147-150.
  • 10Levi J E,Kleter B,Quint W G V,et al.High prevalence of human papillomaviru (HPV) infectons and high freguency of multiple HPV genotypes in human immunodeficinecy virus infected women in Brazil[J].J Clin Microbiol,2002,40(9):3341-3345.

共引文献289

同被引文献16

引证文献3

二级引证文献26

;
使用帮助 返回顶部